• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗磷脂综合征的血栓风险评估:非标准抗体是否有贡献?

Thrombotic risk assessment in antiphospholipid syndrome: do noncriteria antibodies contribute?

机构信息

Division of Rheumatology, Department of Internal Medicine, İstanbul Faculty of Medicine, İstanbul University, İstanbul, Turkiye.

Department of Immunology, Aziz Sancar Institute of Experimental Medicine, İstanbul University, İstanbul, Turkiye.

出版信息

Turk J Med Sci. 2023 Sep 13;53(5):1067-1074. doi: 10.55730/1300-0144.5671. eCollection 2023.

DOI:10.55730/1300-0144.5671
PMID:38813003
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10763812/
Abstract

BACKGROUND/AIM: In this cross-sectional study, it was aimed to test the predictive value of noncriteria antiphospholipid antibodies (aPL) in addition to the global antiphospholipid syndrome score (GAPSS) in predicting vascular thrombosis (VT) in a cohort of patients with APS and aPL (+) systemic lupus erythematosus (SLE).

MATERIAL AND METHODS

This study included 50 patients with primary APS, 68 with SLE/APS, and 52 with aPL (+) SLE who were classified according to VT as VT ± pregnancy morbidity (PM), PM only or aPL (+) SLE. Antiphospholipid serology consisting of lupus anticoagulant (LA), anticardiolipin (aCL) immunoglobulin G (IgG)/IgM/IgA, antibeta2 glycoprotein I (aβ2GPI) IgG/IgM/IgA, antiphosphatidylserine/prothrombin (aPS/PT) IgG/IgM and antidomain-I (aDI) IgG was determined for each patient. The GAPSS and adjusted GAPSS (aGAPSS) were calculated for each patient, as previously defined. Logistic regression analysis was carried out with thrombosis as the dependent variable and high GAPSS, aCL IgA, aβ2GPI IgA, and aDI IgG as independent variables.

RESULTS

The mean GAPSS and aGAPSS of the study population were 11.6 ± 4.4 and 9.6 ± 3.8. Both the VT ± PM APS (n = 105) and PM only APS (n = 13) groups had significantly higher GAPSS and aGAPSS values compared to the aPL (+) SLE (n = 52) group. The patients with recurrent thrombosis had higher aGAPSS but not GAPSS than those with a single thrombotic event. The computed area under the receiver operating characteristic curve demonstrated that a GAPSS ≥13 and aGAPSS ≥10 had the best predictive values for thrombosis. Logistic regression analysis including a GAPSS ≥13, aCL IgA, aβ2GPI IgA, and aDI IgG showed that none of the factors other than a GAPSS ≥13 could predict thrombosis.

CONCLUSION

Both the GAPSS and aGAPSS successfully predict the thrombotic risk in aPL (+) patients and aCL IgA, aβ2GPI IgA, and aDI IgG do not contribute to high a GAPSS or aGAPSS.

摘要

背景/目的:在这项横断面研究中,旨在测试非标准抗磷脂抗体(aPL)在预测血管血栓形成(VT)方面的预测价值,这些抗体除了全球抗磷脂综合征评分(GAPSS)外,还存在于抗磷脂综合征(APS)和抗磷脂抗体(aPL)阳性的系统性红斑狼疮(SLE)患者中。

材料和方法

本研究纳入了 50 例原发性 APS 患者、68 例 SLE/APS 患者和 52 例 aPL(+)SLE 患者,根据 VT 将其分为 VT ±妊娠并发症(PM)、PM 仅发生或 aPL(+)SLE。抗磷脂抗体谱包括狼疮抗凝物(LA)、抗心磷脂(aCL)免疫球蛋白 G(IgG)/IgM/IgA、抗β2 糖蛋白 I(aβ2GPI)IgG/IgM/IgA、抗磷脂酰丝氨酸/凝血酶原(aPS/PT)IgG/IgM 和抗域 I(aDI)IgG,为每位患者确定。如前所述,计算每位患者的 GAPSS 和调整后的 GAPSS(aGAPSS)。以血栓形成为因变量,以高 GAPSS、aCL IgA、aβ2GPI IgA 和 aDI IgG 为自变量,进行逻辑回归分析。

结果

研究人群的平均 GAPSS 和 aGAPSS 分别为 11.6 ± 4.4 和 9.6 ± 3.8。VT ± PM APS(n = 105)和 PM 仅 APS(n = 13)组的 GAPSS 和 aGAPSS 值均显著高于 aPL(+)SLE(n = 52)组。复发性血栓形成患者的 aGAPSS 高于单次血栓形成事件患者,但 GAPSS 无差异。计算接受者操作特征曲线下的面积表明,GAPSS≥13 和 aGAPSS≥10 对血栓形成具有最佳预测价值。包括 GAPSS≥13、aCL IgA、aβ2GPI IgA 和 aDI IgG 的逻辑回归分析表明,除 GAPSS≥13 外,其他因素均不能预测血栓形成。

结论

GAPSS 和 aGAPSS 均可成功预测 aPL(+)患者的血栓形成风险,而 aCL IgA、aβ2GPI IgA 和 aDI IgG 并不能增加 GAPSS 或 aGAPSS 的水平。

相似文献

1
Thrombotic risk assessment in antiphospholipid syndrome: do noncriteria antibodies contribute?抗磷脂综合征的血栓风险评估:非标准抗体是否有贡献?
Turk J Med Sci. 2023 Sep 13;53(5):1067-1074. doi: 10.55730/1300-0144.5671. eCollection 2023.
2
The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.IgA抗磷脂检测在系统性红斑狼疮抗磷脂(休斯)综合征诊断中的价值。
J Rheumatol. 2001 Dec;28(12):2637-43.
3
Validation of the adjusted global antiphospholipid syndrome score in systemic lupus erythematosus patients in Argentina.验证调整后的全球抗磷脂综合征评分在阿根廷系统性红斑狼疮患者中的应用。
Lupus. 2020 Dec;29(14):1866-1872. doi: 10.1177/0961203320960814. Epub 2020 Oct 7.
4
Measuring IgA Anti-β2-Glycoprotein I and IgG/IgA Anti-Domain I Antibodies Adds Value to Current Serological Assays for the Antiphospholipid Syndrome.检测IgA抗β2-糖蛋白I以及IgG/IgA抗结构域I抗体可为目前抗磷脂综合征的血清学检测增添价值。
PLoS One. 2016 Jun 2;11(6):e0156407. doi: 10.1371/journal.pone.0156407. eCollection 2016.
5
Noncriteria antiphospholipid antibodies in antiphospholipid syndrome.抗磷脂综合征中的非标准抗磷脂抗体。
Int J Lab Hematol. 2024 May;46 Suppl 1:34-42. doi: 10.1111/ijlh.14268. Epub 2024 Apr 7.
6
Validation of the adjusted global antiphospholipid syndrome score in a single centre cohort of APS patients from Turkey.验证调整后的全球抗磷脂综合征评分在土耳其 APS 患者单中心队列中的应用。
J Thromb Thrombolysis. 2021 Feb;51(2):466-474. doi: 10.1007/s11239-020-02195-4.
7
Is There an Additional Value in Detecting Anticardiolipin and Anti-β2 glycoprotein I IgA Antibodies in the Antiphospholipid Syndrome?抗磷脂综合征中检测抗心磷脂和抗β2 糖蛋白 I IgA 抗体是否有额外价值?
Thromb Haemost. 2020 Nov;120(11):1557-1568. doi: 10.1055/s-0040-1714653. Epub 2020 Jul 21.
8
Antiphospholipid antibodies in patients with COVID-19: A relevant observation?COVID-19 患者中的抗磷脂抗体:一个相关观察?
J Thromb Haemost. 2020 Sep;18(9):2191-2201. doi: 10.1111/jth.14994. Epub 2020 Jul 23.
9
Anti-Phosphatidylserine/Prothrombin Antibodies at Two Points: Correlation With Lupus Anticoagulant and Thrombotic Risk.抗磷脂酰丝氨酸/凝血酶原抗体两点检测:与狼疮抗凝物及血栓风险的相关性。
Front Immunol. 2021 Oct 21;12:754469. doi: 10.3389/fimmu.2021.754469. eCollection 2021.
10
Thrombotic risk assessment in patients with systemic lupus erythematosus: Validation of the adjusted-Global Antiphospholipid Syndrome Score (aGAPSS) in Thai patients.系统性红斑狼疮患者的血栓风险评估:调整后的全球抗磷脂综合征评分(aGAPSS)在泰国患者中的验证。
Int J Rheum Dis. 2021 Dec;24(12):1510-1519. doi: 10.1111/1756-185X.14230. Epub 2021 Oct 29.

本文引用的文献

1
Predictive value of the adjusted Global Anti-Phospholipid Syndrome Score on clinical recurrence in APS patients: a longitudinal study.调整后的全球抗磷脂综合征评分对抗磷脂综合征患者临床复发的预测价值:一项纵向研究。
Rheumatology (Oxford). 2023 Apr 3;62(4):1576-1585. doi: 10.1093/rheumatology/keac485.
2
Antiphospholipid patterns predict risk of thrombosis in systemic lupus erythematosus.抗磷脂抗体谱预测系统性红斑狼疮血栓形成风险。
Rheumatology (Oxford). 2021 Aug 2;60(8):3770-3777. doi: 10.1093/rheumatology/keaa857.
3
Validation of the adjusted global antiphospholipid syndrome score in systemic lupus erythematosus patients in Argentina.
验证调整后的全球抗磷脂综合征评分在阿根廷系统性红斑狼疮患者中的应用。
Lupus. 2020 Dec;29(14):1866-1872. doi: 10.1177/0961203320960814. Epub 2020 Oct 7.
4
Validation of the adjusted global antiphospholipid syndrome score in a single centre cohort of APS patients from Turkey.验证调整后的全球抗磷脂综合征评分在土耳其 APS 患者单中心队列中的应用。
J Thromb Thrombolysis. 2021 Feb;51(2):466-474. doi: 10.1007/s11239-020-02195-4.
5
Global antiphospholipid syndrome score and anti-ß2-glycoprotein I domain I for thrombotic risk stratification in antiphospholipid syndrome: A four-year prospective study.全球抗磷脂综合征评分和抗β2-糖蛋白 I 结构域 I 对抗磷脂综合征血栓风险分层的评估:一项四年前瞻性研究。
Lupus. 2020 Jun;29(7):676-685. doi: 10.1177/0961203320916527. Epub 2020 Apr 11.
6
2. Classification and Diagnosis of Diabetes: .2. 糖尿病的分类和诊断: 。
Diabetes Care. 2020 Jan;43(Suppl 1):S14-S31. doi: 10.2337/dc20-S002.
7
The adjusted global antiphospholipid syndrome score (aGAPSS) and the risk of recurrent thrombosis: Results from the APS ACTION cohort.调整后的全球抗磷脂综合征评分(aGAPSS)与复发性血栓风险:来自 APS ACTION 队列的结果。
Semin Arthritis Rheum. 2019 Dec;49(3):464-468. doi: 10.1016/j.semarthrit.2019.04.009. Epub 2019 May 2.
8
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.2018年美国心脏协会/美国心脏病学会/美国心血管和肺康复协会/美国医师助理学会/美国心脏协会临床心脏病学分会/美国预防医学学会/美国糖尿病协会/美国老年医学会/美国药剂师协会/美国医学主任协会/美国国家脂质协会/美国初级保健医师学会血液胆固醇管理指南:美国心脏病学会/美国心脏协会临床实践指南工作组报告
J Am Coll Cardiol. 2019 Jun 25;73(24):e285-e350. doi: 10.1016/j.jacc.2018.11.003. Epub 2018 Nov 10.
9
2018 ESC/ESH Guidelines for the management of arterial hypertension.2018年欧洲心脏病学会/欧洲高血压学会动脉高血压管理指南。
Eur Heart J. 2018 Sep 1;39(33):3021-3104. doi: 10.1093/eurheartj/ehy339.
10
Added value of non-criteria antiphospholipid antibodies for antiphospholipid syndrome: lessons learned from year-long routine measurements.非标准抗磷脂抗体对抗磷脂综合征的附加价值:来自长达一年的常规测量中得到的经验教训。
Clin Rheumatol. 2019 Feb;38(2):371-378. doi: 10.1007/s10067-018-4251-7. Epub 2018 Aug 11.